90 related articles for article (PubMed ID: 2573987)
1. [Dopamine deficiency syndrome in children with specific reaction to the treatment with levodopa preparations].
Shoshina LM; Grinio LP; Mineeva MF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):27-32. PubMed ID: 2573987
[TBL] [Abstract][Full Text] [Related]
2. Dopamine deficiency syndrome in children with a special reaction to treatment with levodopa preparations.
Shoshina LM; Grinio LP; Mineeva MF
Neurosci Behav Physiol; 1990; 20(5):395-400. PubMed ID: 1981806
[TBL] [Abstract][Full Text] [Related]
3. [Clinical results of using Nakom in diseases of the nervous system].
Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
[TBL] [Abstract][Full Text] [Related]
4. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
Bondarenko ES; Malyshev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis and treatment of torsion dystonia].
Barkhatova VP; Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1121-8. PubMed ID: 696099
[TBL] [Abstract][Full Text] [Related]
6. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Zimmerman TR; Sage JI; Lang AE; Mark MH
Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
[TBL] [Abstract][Full Text] [Related]
7. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
8. [Recessive dopa-responsive form of dystonia due to a mutation of the tyrosine hydroxylase gene].
Rondot P; Wevers RA
Bull Acad Natl Med; 1999; 183(3):639-46; discussion 646-7. PubMed ID: 10437291
[TBL] [Abstract][Full Text] [Related]
9. Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations.
Deleu D; Jacques M; Michotte Y; Ebinger G
Neurology; 1989 Nov; 39(11 Suppl 2):88-92; discussion 95. PubMed ID: 2685654
[TBL] [Abstract][Full Text] [Related]
10. [Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
Brin IL; Drozdov AZ; Kovaleva IA; Filatova TS; Kogan BM
Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):7-12. PubMed ID: 7975996
[TBL] [Abstract][Full Text] [Related]
11. Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
Rondot P; Ziegler M; Aymard N; Teinturier A
Neurology; 1989 Nov; 39(11 Suppl 2):74-7; discussion 95. PubMed ID: 2586765
[TBL] [Abstract][Full Text] [Related]
12. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
13. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
14. Fluctuating dystonia and allied syndromes.
Gordon N
Neuropediatrics; 1982 Aug; 13(3):152-4. PubMed ID: 7133334
[TBL] [Abstract][Full Text] [Related]
15. Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies.
LeWitt PA; Nelson MV; Berchou RC; Galloway MP; Kesaree N; Kareti D; Schlick P
Neurology; 1989 Nov; 39(11 Suppl 2):45-53; discussion 59. PubMed ID: 2685650
[TBL] [Abstract][Full Text] [Related]
16. Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy.
Sage JI; Duvoisin RC
Mov Disord; 1986; 1(4):267-70. PubMed ID: 3504249
[TBL] [Abstract][Full Text] [Related]
17. Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel function.
Iyer SS; Morgan JC; Sethi KD
Neurology; 2005 Nov; 65(9):1507. PubMed ID: 16275853
[No Abstract] [Full Text] [Related]
18. [Treatment of dystonia musculorum deformans].
Minich LN
Zdravookhr Kirg; 1977; (3):30-3. PubMed ID: 22183
[No Abstract] [Full Text] [Related]
19. [Familial dystonia: a case of idiopathic torsion dystonia].
Skłodowski P
Neurol Neurochir Pol; 1998; 32(5):1261-6. PubMed ID: 10463238
[TBL] [Abstract][Full Text] [Related]
20. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
